We are live on ! Find out more
MD icon

Pediatrix Medical

320 hedge funds and large institutions have $4.14B invested in Pediatrix Medical in 2018 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 109 increasing their positions, 117 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more call options, than puts

Call options by funds: $5.45M | Put options by funds: $4.88M

6% more capital invested

Capital invested by funds: $3.91B → $4.14B (+$232M)

5% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 42

0.61% less ownership

Funds ownership: 95.5%94.89% (-0.61%)

1% less funds holding

Funds holding: 322320 (-2)

7% less repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 117

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
320
Holders Change
-2
Holders Change %
-0.62%
% of All Funds
7.31%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
44
Increased
109
Reduced
117
Closed
42
Calls
$5.45M
Puts
$4.88M
Net Calls
+$578K
Net Calls Change
-$3.93M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$393M -$6.32M -137,732 -2%
BlackRock
2
BlackRock
New York
$390M +$10.4M +227,101 +3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$386M +$14.4M +314,415 +4%
BHG
4
Blue Harbour Group
Connecticut
$194M
Pzena Investment Management
5
Pzena Investment Management
New York
$152M +$43.8M +954,322 +41%
State Street
6
State Street
Massachusetts
$122M +$2.12M +46,180 +2%
CS
7
Credit Suisse
Switzerland
$114M -$39M -850,258 -26%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$104M +$2.33M +50,806 +2%
EM
9
Elliott Management
New York
$95.2M -$19.9M -434,000 -18%
EARNEST Partners
10
EARNEST Partners
Georgia
$90.6M -$24.6K -536 -0%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$89.4M -$1.55M -33,833 -2%
ACH
12
ArrowMark Colorado Holdings
Colorado
$87.3M +$8.41M +183,236 +11%
PCP
13
P2 Capital Partners
New York
$84M +$178K +3,871 +0.2%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$82.4M +$23M +500,538 +40%
Nordea Investment Management
15
Nordea Investment Management
Sweden
$79.9M -$5.26M -114,531 -6%
O
16
OrbiMed
New York
$68.6M +$27.9M +606,700 +70%
Fidelity International
17
Fidelity International
Bermuda
$62.9M +$103K +2,233 +0.2%
Millennium Management
18
Millennium Management
New York
$53.7M +$37.5M +817,274 +245%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$52.2M +$9.45M +205,918 +23%
WCM
20
Wedge Capital Management
North Carolina
$50.3M -$8.71M -189,776 -15%
Norges Bank
21
Norges Bank
Norway
$48.3M +$5M +108,886 +12%
Citadel Advisors
22
Citadel Advisors
Florida
$45.4M +$23.3M +508,033 +109%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$43.3M +$1.21M +26,256 +3%
Northern Trust
24
Northern Trust
Illinois
$37.8M -$1.99M -43,421 -5%
MSE
25
MUFG Securities EMEA
United Kingdom
$37.3M +$18.4M +400,000 +100%

MD Hedge Fund Activity: Q3 2018 in Review

320 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q3 2018, worth a combined $4.14B — up 5.9% from $3.91B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new MD positions and 42 closed out — a net gain of 2 holders — while 109 added to existing stakes and 117 trimmed.

The largest buyer was Pzena Investment Management, adding an estimated $43.8M. The largest seller was Thompson Siegel & Walmsley, cutting an estimated $64.8M.

  • 320 institutional investors held Pediatrix Medical (MD) as of Q3 2018, down from 322 in Q2 2018.
  • Funds reported $4.14B of Pediatrix Medical stock for Q3 2018, up 5.9% quarter-over-quarter.
  • 44 funds opened new Pediatrix Medical positions in Q3 2018 and 42 closed out, a net change of +2 holders.
  • The largest Pediatrix Medical buyer in Q3 2018 was Pzena Investment Management, an estimated $43.8M added.
  • The largest Pediatrix Medical seller in Q3 2018 was Thompson Siegel & Walmsley, an estimated $64.8M sold.

Based on aggregated 13F filings for Q3 2018.